Anzeige
Mehr »
Dienstag, 12.08.2025 - Börsentäglich über 12.000 News
Diese Aktie liegt in der Turbo-Zone - und könnte der Gold-Gewinner 2025/26 werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.07.Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-001
30.07.Evotec, Sandoz Announce Potential Sale of Just - Evotec Biologics EU
30.07.Tobin Scientific Acquires Wakefield Moving & Storage
30.07.BioDuro, Atombeat Launch AI-Powered Platform for Accelerated Peptide Drug Discovery
29.07.Hansa Biopharma Makes Leadership Appointments
29.07.Flashpoint Therapeutics Appoints Barry Labinger as CEO
29.07.Asahi Kasei Life Science to Build New Spinning Plant for Virus Removal Filters
29.07.Novo Nordisk Appoints New President & CEO
29.07.ViroCell Biologics Delivers Novel Retroviral Vector to AvenCell Therapeutics for Allogeneic CAR-T Therapy
28.07.Boehringer Ingelheim and Re-Vana Therapeutics Partner on Long-Acting Ophthalmics
28.07.GSK, Hengrui Sign $500M Drug Development Pact
28.07.Veranova Appoints Thomas Rohrer VP of Bioconjugation
28.07.Pistoia Alliance Launches New Initiatives to Enhance Pharmacovigilance
28.07.CS Analytical Launches Gas Testing Analytical
28.07.Lilly Acquires Verve Therapeutics
28.07.ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer
28.07.MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine
28.07.AstraZeneca's sBLA for IMFINZI Accepted and Granted Priority Review
25.07.Simtra Purchases 65-Acre Property in Indiana
25.07.Sanofi's Sarclisa Gains EU Approval for Multiple Myeloma
25.07.Bristol Myers Squibb Names New EVP, Chief Medical Officer and Head of Development
24.07.Matchpoint Therapeutics, Novartis Partner to Develop Covalent Medicines for Inflammatory Diseases
24.07.Verastem Oncology's VS-7375 Granted Fast Track Designation by the FDA
24.07.Pfizer Bolsters Oncology Pipeline with $1.25B 3SBio Deal
23.07.Stevanato Group Secures $235.4 Million in Financing